XARACOLL: Innocoll Holdings Limited

 Xaracoll

FDA Approval date: 28 August 2020

Company Name: Innocoll Holdings Limited

Generic Name: bupivacaine Hydrochloride 

Dosage Form: Implant

Xaracoll is a type of implant which consist of Bupivacaine Hydrochloride. These implant is being used for the post surgical pain relief up to 24hours. Xaracoll is placed at the site of operation and the drug is released through the diffusion. These is the collagen implant which is dissolved over a time.